ArticleJournal of cardiovascular imaging2026
Segmental strain in chronic ischemic cardiomyopathy: clarifying the role of multiple-comparison adjustment and the clinical interpretation of limits of agreement.
Article in Journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Khidr and colleagues recently reported an intermodality comparison of left ventricular longitudinal strain by feature-tracking cardiac magnetic resonance (FT-CMR) and 2D speckle-tracking echocardiography (2D-STE) in 55 stable patients with chronic ischemic heart disease and reduced ejection fraction. Their analysis showed a strong global longitudinal strain (GLS) correlation (r = 0.793, P < 0.001) and explicitly cautioned against treating the two modalities as interchangeable for individual or longitudinal assessment. We support these conclusions and write to extend two methodological points. First, the 17 segment-level paired comparisons in Table 4 are reported without explicit multiplicity adjustment. On recomputation against a Bonferroni threshold of α/17≈0.00294, 11 of 17 segmental differences remain statistically significant, indicating that the original segmental signal is more statistically robust than an unadjusted reader might assume; we therefore recommend explicit reporting of adjusted P-values together with a unified mixed-effects formulation that accommodates within-patient segment-to-segment correlation. Second, the GLS limits of agreement span 8.3 percentage points (- 3.2% to + 5.1%), a width sufficient to misclassify individual patients across established GLS thresholds. A worked example is provided, and the recommendation to confine longitudinal follow-up to a single platform is argued to deserve more prominent placement in the Abstract and Conclusions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.